Skip to main content
Premium Trial:

Request an Annual Quote

Microbial Genetics Analysis Company OpGen Receives CLIA Accreditation

NEW YORK (GenomeWeb News) – Microbioal genetic analysis firm OpGen today announced it has received Clinical Laboratory Improvement Amendments certification.

As a result, the Gaithersburg, Md.-based firm is launching its clinical services lab focused on developing genetic tests and analysis services for surveilling and identifying healthcare-associated infections and human pathogens.

OpGen's clinical services lab uses next-generation DNA and genetic analysis technology, including multiplex real-time PCR, whole genome mapping, and next-generation sequencing. As a result, it can offer low cost genetic testing for the screening, surveillance, diagnosis, gene content, and epidemiological analysis of infectious diseases, it said.

It offers whole genome mapping genetic analysis of HAIs, and sequence analysis of C. difficile on a worldwide basis, and it will offer real-time PCR screening and surveillance of MRSA and complete C. difficile hypervirulence diagnostic testing services in the mid-Atlantic region.

Additionally, OpGen is developing tests for gram-negative and gram-positive multidrug resistant organisms, it said.

"OpGen is building on the success of our whole genome mapping applications in the public health and life sciences sectors to expand our capabilities to help hospitals and healthcare facilities combat HAIs and complex human pathogens, OpGen CEO Douglas White said in a statement. "With the opening of our CLIA-certified laboratory, OpGen will provide a unique, comprehensive offering of infectious disease screening, diagnostic, and epidemiology services."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.